Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.

Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1328-35. doi: 10.1016/j.ijrobp.2010.07.1993. Epub 2010 Oct 8.

2.

The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer.

La Torre M, Mazzuca F, Ferri M, Mari FS, Botticelli A, Pilozzi E, Lorenzon L, Osti MF, Marchetti P, Enrici RM, Ziparo V.

Colorectal Dis. 2013 Jul;15(7):e382-8. doi: 10.1111/codi.12242.

PMID:
23581854
3.

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Berger AC, Watson JC, Ross EA, Hoffman JP.

Am Surg. 2004 Mar;70(3):235-40; discussion 240.

PMID:
15055847
4.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
5.

Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.

Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, Wu XB, Cai JH, Zhou ZH, Li JL, Song HY, Luo ZQ, Li P, Ni SC, Jiang L.

Medicine (Baltimore). 2016 Mar;95(9):e2988. doi: 10.1097/MD.0000000000002988.

6.

Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?

Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1047-54. doi: 10.1097/MEG.0000000000000162.

PMID:
25051217
7.

Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation.

Bhatti AB, Akbar A, Hafeez A, Syed AA, Khattak S, Jamshed A, Kazmi AS.

Int J Surg. 2015 Jan;13:65-70. doi: 10.1016/j.ijsu.2014.11.038. Epub 2014 Dec 2.

8.

Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.

Shamseddine AI, Mukherji D, Melki C, Elias E, Eloubeidi M, Dimassi H, Khalife M, Abou-Alfa G, O'Reilly E, Faraj W.

Am J Clin Oncol. 2014 Feb;37(1):13-8. doi: 10.1097/COC.0b013e31826b9c74.

PMID:
23111358
9.

Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Shridhar R, Cannick L, Marshall DT.

Am J Clin Oncol. 2014 Apr;37(2):112-6. doi: 10.1097/COC.0b013e31826e0570.

10.

lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.

Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.

PMID:
19289261
11.

Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Lee SD, Kim TH, Kim DY, Baek JY, Kim SY, Chang HJ, Park SC, Park JW, Oh JH, Jung KH.

Eur J Surg Oncol. 2012 Jun;38(6):478-83. doi: 10.1016/j.ejso.2012.03.002. Epub 2012 Mar 30.

PMID:
22465588
12.

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.

Surgery. 2007 May;141(5):610-8. Epub 2007 Mar 23.

PMID:
17462460
13.

Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.

Ashfaq A, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N.

J Gastrointest Surg. 2014 Nov;18(11):1929-35. doi: 10.1007/s11605-014-2566-5. Epub 2014 Jun 11.

PMID:
24916590
14.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group..

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
15.

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.

Solak M, Turkoz FP, Keskin O, Aksoy S, Babacan T, Sarici F, Kertmen N, Sever AR, Altundag K.

J BUON. 2015 May-Jun;20(3):737-45.

PMID:
26214625
16.
17.

Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H.

Cancer. 2012 Jan 1;118(1):268-77. doi: 10.1002/cncr.26243. Epub 2011 Jul 6.

18.

Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.

Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI.

World J Surg. 2010 Apr;34(4):768-75. doi: 10.1007/s00268-009-0336-4.

PMID:
20052471
19.

Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.

Wang QX, Cai YF, Chen YY, Zhang W, Jin WX, Chen ED, Zhang XH, Li Q.

Ann Clin Lab Sci. 2017 Jan;47(1):68-75.

PMID:
28249920
20.

The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.

Qiu C, Dong W, Su B, Liu Q, Du J.

J Thorac Oncol. 2013 Apr;8(4):429-35. doi: 10.1097/JTO.0b013e3182829c16.

Supplemental Content

Support Center